{"doc_id": "si-2021-0260-reg-1", "parent_doc_id": "si-2021-0260", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "1. These Regulations may be cited as the European Union (National", "text_raw": "1. These Regulations may be cited as the European Union (National \nResearch Ethics Committee for Clinical Investigations of Medical Devices) \nRegulations 2021. \n\nCommencement", "text_norm": "1 regulation may cited european union (national research ethic committee clinical investigation medical devices) regulation 2021 commencement", "start_char": 819, "end_char": 996, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-2", "parent_doc_id": "si-2021-0260", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "2. These Regulations come into operation on 26 May 2021.", "text_raw": "2. These Regulations come into operation on 26 May 2021. \n\nInterpretation", "text_norm": "2 regulation come operation 26 may 2021 interpretation", "start_char": 996, "end_char": 1072, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-3", "parent_doc_id": "si-2021-0260", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "3. (1) In these Regulations—", "text_raw": "3. (1) In these Regulations— \n\n“Authority” means the Health Products Regulatory Authority; \n\n“EU Regulation” means Regulation (EU) 2017/745 of the European Parliament \nand of the Council of 5 April 20171, as amended by Regulation (EU) 2020/561 \nof the European Parliament and of the Council of 23 April 20202; \n\n“expert member” means a member of a National REC who– \n\n(a) \n\nis a practising or retired health practitioner, \n\n(b) has qualifications in, or experience directly relating to, the \nconduct of health research (other than as a member of a research \nethics committee), or \n\n(c) \n\nhas qualifications or experience in the area of ethics; \n\n“lay member” means a member of a National REC who is not an expert member; \n\n“Minister” means the Minister for Health; \n\n“National REC” means a committee established under Regulation 4; \n\n“opinion” means a decision issued under Regulation 13(1). \n\n1 OJ No. L 117, 5.5.2017, p. 1. \n2 OJ No. L 130, 24.4.2020, p. 18. \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 28th May, 2021. \n\n \n \n \n \n \n \n \n \n\f[260] 3 \n\n(2) A word or expression which is used in these Regulations and which is \nalso used in the EU Regulation has, unless the context otherwise requires, the \nsame meaning in these Regulations as it has in the EU Regulation. \n\nEstablishment and functions of national research ethics committee", "text_norm": "3 (1) regulations-- authority mean health product regulatory authority eu regulation mean regulation (eu) 2017 745 european parliament council 5 april 20171 amended regulation (eu) 2020 561 european parliament council 23 april 20202 expert member mean member national rec who- (a) practising retired health practitioner (b) qualification experience directly relating conduct health research (other member research ethic committee) (c) qualification experience area ethic lay member mean member national rec expert member minister mean minister health national rec mean committee established regulation 4 opinion mean decision issued regulation 13(1) 1 oj no l 117 5.5.2017 p 1 2 oj no l 130 24.4.2020 p 18 notice making statutory instrument published iris oifigiuil 28th may 2021 260 3 (2) word expression used regulation also used eu regulation unless context otherwise requires meaning regulation eu regulation establishment function national research ethic committee", "start_char": 1072, "end_char": 2458, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-4", "parent_doc_id": "si-2021-0260", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "4. (1) The Minister may, from time to time, establish one or more than one,", "text_raw": "4. (1) The Minister may, from time to time, establish one or more than one, \ncommittee to perform ethical review, and give opinions, valid for the entire State, \nof clinical investigations under the EU Regulation, and a committee so \nestablished is, in these Regulations, referred to as a “National REC”. \n\n(2) The functions of a National REC are those set out in these Regulations \nand include such incidental, supplementary and consequential actions as are \nnecessary or expedient for the purposes of carrying out those functions. \n\nMembership and operation of National RECs", "text_norm": "4 (1) minister may time time establish one one committee perform ethical review give opinion valid entire state clinical investigation eu regulation committee established regulation referred national rec  (2) function national rec set regulation include incidental supplementary consequential action necessary expedient purpose carrying function membership operation national recs", "start_char": 2458, "end_char": 3037, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-5", "parent_doc_id": "si-2021-0260", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "5. (1) The Minister shall, subject to this Regulation and the Schedule,", "text_raw": "5. (1) The Minister shall, subject to this Regulation and the Schedule, \n\nappoint the members of a National REC. \n\n(2) A National REC shall consist of expert members and lay members who, \nhaving regard to the functions of the National REC concerned, are suitably \nqualified in terms of diversity of skills, qualifications, interests and backgrounds \nto make decisions on applications likely to be made to the National REC, and in \nrelation to lay members particular regard should be given to individuals who are \npatients or representatives of patient organisations. \n\n(3) The Minister shall not appoint a person to be a member of a National \nREC unless the Minister is satisfied that the person is a fit and proper person to \nbe so appointed. \n\n(4) The rules and procedures set out in the Schedule shall apply to the \n\nmembership and operation of a National REC. \n\nProhibition on seeking or receiving payments or benefits", "text_norm": "5 (1) minister shall subject regulation schedule appoint member national rec (2) national rec shall consist expert member lay member regard function national rec concerned suitably qualified term diversity skill qualification interest background make decision application likely made national rec relation lay member particular regard given individual patient representative patient organisation (3) minister shall appoint person member national rec unless minister satisfied person fit proper person appointed (4) rule procedure set schedule shall apply membership operation national rec prohibition seeking receiving payment benefit", "start_char": 3037, "end_char": 3962, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-6", "parent_doc_id": "si-2021-0260", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "6. (1) Subject to paragraph (2) of this Regulation and paragraph (7) of the", "text_raw": "6. (1) Subject to paragraph (2) of this Regulation and paragraph (7) of the \nSchedule, a member of a National REC or an appeal panel may not seek or \nreceive any payment, fee or financial or other benefit in respect of any \napplication or appeal under these Regulations. \n\n(2) Where a member of a National REC or appeal panel receives any \npayment, fee or financial or other benefit from a person in respect of any \napplication or appeal under these Regulations as appropriate, he or she shall \nreturn it to the person concerned and shall, as soon as practicable, advise the \nNational REC accordingly. \n\nSub-committees of National RECs", "text_norm": "6 (1) subject paragraph (2) regulation paragraph (7) schedule member national rec appeal panel may seek receive payment fee financial benefit respect application appeal regulation (2) member national rec appeal panel receives payment fee financial benefit person respect application appeal regulation appropriate shall return person concerned shall soon practicable advise national rec accordingly sub-committees national recs", "start_char": 3962, "end_char": 4600, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-7", "parent_doc_id": "si-2021-0260", "section_id": "reg-7", "section_label": "Regulation 7.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "7. (1) A National REC may establish one or more sub-committees to provide", "text_raw": "7. (1) A National REC may establish one or more sub-committees to provide \n\nadvice and assistance to the National REC. \n\n \n \n \n \n \n\f4 [260] \n\n(2) Each member of a sub-committee established under paragraph (1) shall \n\nbe a member of the National REC concerned. \n\n(3) The acts of a sub-committee are subject to confirmation by the National \nREC concerned unless the National REC dispenses with the necessity for such \nconfirmation. \n\n(4) A National REC may, at any time, dissolve a sub-committee established \n\nunder paragraph (1). \n\n(5) A decision on an application made under Regulation 8(1) may not be \n\nmade by a sub-committee established under paragraph (1). \n\nApplications for ethical review", "text_norm": "7 (1) national rec may establish one sub-committees provide advice assistance national rec 4 260 (2) member sub-committee established paragraph (1) shall member national rec concerned (3) act sub-committee subject confirmation national rec concerned unless national rec dispenses necessity confirmation (4) national rec may time dissolve sub-committee established paragraph (1) (5) decision application made regulation 8(1) may made sub-committee established paragraph (1) application ethical review", "start_char": 4600, "end_char": 5297, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-8", "parent_doc_id": "si-2021-0260", "section_id": "reg-8", "section_label": "Regulation 8.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "8. (1) A sponsor proposing to carry out a clinical investigation in the State", "text_raw": "8. (1) A sponsor proposing to carry out a clinical investigation in the State \nfor the purpose of the EU Regulation shall apply to the relevant National REC \nfor review of the ethical aspects of the proposed research. \n\n(2) A sponsor of a clinical investigation which is being or to be conducted in \nthe State, who intends to introduce modifications to which Article 75 of the EU \nRegulation applies, shall apply to the relevant National REC for approval \npursuant to that Article. \n\n(3) The National REC may, as appropriate, coordinate with the Authority, \n\nincluding in relation to— \n\n(a) \n\n(b) \n\nthe initial and ongoing assessment of applications under \nparagraphs (1) and (2), \n\nthe follow-up on authorised clinical investigations, including in \nrelation to any modifications, and \n\n(c) \n\nthe execution of tasks pursuant to the EU Regulation. \n\n(4) An application under paragraph (1) shall be— \n\n(a) \n\nsubmitted no later than the time of submission of the application \nto the Authority for authorisation or notification of the clinical \ninvestigation, \n\n(b) made in the form and manner specified by the National REC, and \n\n(c) \n\naccompanied by the specified fee, if any. \n\n(5) The National REC shall, as a preliminary matter, and in consultation with \nthe Authority as appropriate, decide whether an application under paragraph (1) \nor (2) is— \n\n(a) one to which the EU Regulation applies, or \n\n(b) one to which the EU Regulation does not apply, \n\nand shall notify the applicant accordingly. \n\n \n \n \n \n \n\f[260] 5 \n\nConsultation by National REC", "text_norm": "8 (1) sponsor proposing carry clinical investigation state purpose eu regulation shall apply relevant national rec review ethical aspect proposed research (2) sponsor clinical investigation conducted state intends introduce modification article 75 eu regulation applies shall apply relevant national rec approval pursuant article (3) national rec may appropriate coordinate authority including relation to-- (a) (b) initial ongoing assessment application paragraph (1) (2) follow-up authorised clinical investigation including relation modification (c) execution task pursuant eu regulation (4) application paragraph (1) shall be-- (a) submitted later time submission application authority authorisation notification clinical investigation (b) made form manner specified national rec (c) accompanied specified fee any (5) national rec shall preliminary matter consultation authority appropriate decide whether application paragraph (1) (2) is-- (a) one eu regulation applies (b) one eu regulation apply shall notify applicant accordingly 260 5 consultation national rec", "start_char": 5297, "end_char": 6847, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-9", "parent_doc_id": "si-2021-0260", "section_id": "reg-9", "section_label": "Regulation 9.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "9. (1) In considering an application under Regulation 8(1) or (2), a National", "text_raw": "9. (1) In considering an application under Regulation 8(1) or (2), a National \nREC may consult with a person who is not a member of the National REC where \nit considers that that person has an expertise required by the National REC. \n\n(2) The views of a person consulted under paragraph (1) shall be recorded \nby the National REC in the minutes of the meeting at which the proposal \nconcerned is considered. \n\n(3) A person who is consulted under paragraph (1) shall, as soon as he or she \nbecomes aware of it, advise the National REC of any interest or association he \nor she may have in or with the proposal being considered. \n\nEthical considerations and timelines on applications", "text_norm": "9 (1) considering application regulation 8(1) (2) national rec may consult person member national rec considers person expertise required national rec (2) view person consulted paragraph (1) shall recorded national rec minute meeting proposal concerned considered (3) person consulted paragraph (1) shall soon becomes aware advise national rec interest association may proposal considered ethical consideration timeline application", "start_char": 6847, "end_char": 7531, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-10", "parent_doc_id": "si-2021-0260", "section_id": "reg-10", "section_label": "Regulation 10.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "10. (1) A National REC to which an application is made under Regulation", "text_raw": "10. (1) A National REC to which an application is made under Regulation \n8(1) or (2) shall consider the ethics of the proposed clinical investigation and, \nsubject to paragraphs (2) and (3), shall within the specified period following \nreceipt of the application give an opinion in relation to the clinical investigation \nto which the application relates. \n\n(2) Where, following receipt of an application under Regulation 8(1) or (2), \nit appears to the National REC that further information is required in order to \ngive an opinion, the National REC may, within the specified period and before \ngiving its opinion, send a notice in writing to the applicant, that he or she \nprovides such information to the National REC. \n\n(3) Where the National REC sends a request in accordance with paragraph \n(2), the specified period shall be suspended pending receipt of the information \nrequested. \n\n(4) The National REC may, as deemed necessary, consult a specialist sub-\n\ncommittee, or a person referred to in Regulation 9, before giving its opinion. \n\n(5) In preparing its opinion, the National REC shall consider, in particular \n\nand where applicable, the following matters: \n\n(a) whether there is compliance with the requirements of Article 62 \nof the EU Regulation as they apply to ethical considerations; \n\n(b) \n\nthe relevance of the clinical investigation and its design; \n\n(c) whether the evaluation of the anticipated benefits and risks is \n\nsatisfactory and whether the conclusions are justified; \n\n(d) \n\nthe clinical investigation protocol; \n\n(e) \n\nthe suitability of the investigator and supporting staff; \n\n(f) \n\n(g) \n\nthe investigator’s brochure; \n\nthe quality and adequacy of the facilities for the clinical \ninvestigation; \n\n(h) whether the clinical investigation has been designed to involve as \nlittle pain, discomfort, fear and any other foreseeable risk as \npossible for the subjects, and both the risk threshold and the \n\n \n \n\f6 [260] \n\ndegree of distress are specifically defined in the clinical \ninvestigation plan and constantly monitored; \n\n(i) whether any undue influence, including that of a financial nature, \nis exerted on the subject, or, where applicable, on his or her \nlegally designated representatives, to participate in the clinical \ninvestigation; \n\n(j) whether vulnerable population subjects are appropriately \nprotected in accordance with Articles 64 to 68 of the EU \nRegulation; \n\n(k) \n\n(l) \n\n(m) \n\n(n) \n\n(o) \n\n(p) \n\n(q) \n\nthe adequacy and completeness of the written information to be \ngiven and the procedure to be followed for the purpose of \nobtaining informed consent to participation in the clinical \ninvestigation; \n\nif the subjects are to include persons who because they are minors \nare incapable of giving informed consent, whether the research is \njustified having regard to Article 65 of the EU Regulation; \n\nif the subjects are to include persons who are adults and who are \nincapable by reason of physical or mental incapacity of giving \ninformed consent, whether the research is justified having regard \nto Article 64 of the EU Regulation; \n\nthe arrangements for the recruitment of subjects; \n\nthe provision made for indemnity or compensation in the event of \ninjury or death attributable to the clinical investigation in \naccordance with Regulation 11; \n\nthe amounts and, where appropriate, the arrangements for \nrewarding or compensating investigators and investigation \nsubjects; and \n\nthe terms of any agreement between the sponsor and the owner or \noccupier of the investigation site which are relevant to the \narrangements referred to in subparagraph (p). \n\n(6) If any subject participating in a clinical investigation is to be a minor and \nthe National REC does not have a member with professional expertise in \npaediatrics, it shall, before giving its opinion, obtain advice on the clinical, \nethical and psychosocial concerns specific to the field of paediatrics which may \narise in relation to that investigation. \n\n(7) If any subject participating in a clinical investigation is to be an adult \nincapable by reason of physical or mental incapacity of giving informed consent \nto participation in the investigation and the National REC does not have a \nmember with professional expertise in the treatment of— \n\n(a) \n\n(b) \n\nthe disease to which the investigation relates, and \n\nthe patient population suffering that disease, \n\nit shall, before giving its opinion, obtain advice on the clinical, ethical and \npsychosocial concerns, in the field of that disease and the patient population \nconcerned, which may arise in relation to that investigation. \n\n \n\f[260] 7 \n\n(8) In this Regulation, “specified period” means— \n\n(a) \n\nin the case of an application under Regulation 8(1), 55 days or \nsuch extended period as may be required by the National REC \nwhere consultation is required, and \n\n(b) \n\nin the case of an application under Regulation 8(2), 38 days, or \n45 days where consultation is required. \n\nDamage compensation in clinical investigations", "text_norm": "10 (1) national rec application made regulation 8(1) (2) shall consider ethic proposed clinical investigation subject paragraph (2) (3) shall within specified period following receipt application give opinion relation clinical investigation application relates (2) following receipt application regulation 8(1) (2) appears national rec information required order give opinion national rec may within specified period giving opinion send notice writing applicant provides information national rec (3) national rec sends request accordance paragraph (2) specified period shall suspended pending receipt information requested (4) national rec may deemed necessary consult specialist sub- committee person referred regulation 9 giving opinion (5) preparing opinion national rec shall consider particular applicable following matter (a) whether compliance requirement article 62 eu regulation apply ethical consideration (b) relevance clinical investigation design (c) whether evaluation anticipated benefit risk satisfactory whether conclusion justified (d) clinical investigation protocol (e) suitability investigator supporting staff (f) (g) investigator brochure quality adequacy facility clinical investigation (h) whether clinical investigation designed involve little pain discomfort fear foreseeable risk possible subject risk threshold 6 260 degree distress specifically defined clinical investigation plan constantly monitored (i) whether undue influence including financial nature exerted subject applicable legally designated representative participate clinical investigation (j) whether vulnerable population subject appropriately protected accordance article 64 68 eu regulation (k) (l) (m) (n) (o) (p) (q) adequacy completeness written information given procedure followed purpose obtaining informed consent participation clinical investigation subject include person minor incapable giving informed consent whether research justified regard article 65 eu regulation subject include person adult incapable reason physical mental incapacity giving informed consent whether research justified regard article 64 eu regulation arrangement recruitment subject provision made indemnity compensation event injury death attributable clinical investigation accordance regulation 11 amount appropriate arrangement rewarding compensating investigator investigation subject term agreement sponsor owner occupier investigation site relevant arrangement referred subparagraph (p) (6) subject participating clinical investigation minor national rec member professional expertise paediatrics shall giving opinion obtain advice clinical ethical psychosocial concern specific field paediatrics may arise relation investigation (7) subject participating clinical investigation adult incapable reason physical mental incapacity giving informed consent participation investigation national rec member professional expertise treatment of-- (a) (b) disease investigation relates patient population suffering disease shall giving opinion obtain advice clinical ethical psychosocial concern field disease patient population concerned may arise relation investigation 260 7 (8) regulation specified period means-- (a) case application regulation 8(1) 55 day extended period may required national rec consultation required (b) case application regulation 8(2) 38 day 45 day consultation required damage compensation clinical investigation", "start_char": 7531, "end_char": 12537, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-11", "parent_doc_id": "si-2021-0260", "section_id": "reg-11", "section_label": "Regulation 11.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "11. A clinical investigation shall not be approved under these Regulations or", "text_raw": "11. A clinical investigation shall not be approved under these Regulations or \nconducted unless there is in place a policy of insurance or indemnity scheme to \nprovide compensation for any damage suffered by a subject resulting from \nparticipation in the clinical investigation, which policy or scheme shall be \nappropriate to the nature and the extent of the risk. \n\nConsideration of proposals by divisions of National REC", "text_norm": "11 clinical investigation shall approved regulation conducted unless place policy insurance indemnity scheme provide compensation damage suffered subject resulting participation clinical investigation policy scheme shall appropriate nature extent risk consideration proposal division national rec", "start_char": 12537, "end_char": 12963, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-12", "parent_doc_id": "si-2021-0260", "section_id": "reg-12", "section_label": "Regulation 12.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "12. For the purposes of the effective and efficient consideration of", "text_raw": "12. For the purposes of the effective and efficient consideration of \napplications under Regulation 8(1) or (2), the Chairperson of the National REC, \nafter consulting with the Deputy Chairpersons, may determine that the National \nREC shall sit in divisions of not less than seven members. \n\nOpinions on applications", "text_norm": "12 purpose effective efficient consideration application regulation 8(1) (2) chairperson national rec consulting deputy chairperson may determine national rec shall sit division le seven member opinion application", "start_char": 12963, "end_char": 13282, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-13", "parent_doc_id": "si-2021-0260", "section_id": "reg-13", "section_label": "Regulation 13.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "13. (1) Where the National REC has considered the relevant matters in an", "text_raw": "13. (1) Where the National REC has considered the relevant matters in an \napplication under Regulation 8(1) or (2) in accordance with the EU Regulation \nand these Regulations, the National REC shall issue a decision (in these \nRegulations referred to as an “opinion”)— \n\n(a) \n\nrefusing to give its ethical approval if it is satisfied that one or \nmore of those matters has not been met, or \n\n(b) giving its ethical approval to the proposal if it is satisfied that \n\nthose matters have been met. \n\n(2) The National REC shall notify— \n\n(a) \n\n(b) \n\nthe applicant, and \n\nthe Authority \n\nin writing of its opinion under paragraph (1). \n\n(3) If the opinion of the National REC is that the application is approved \n(with or without conditions), the notification under paragraph (2) shall include a \nstatement of— \n\n(a) \n\nconditions, if any, to which the clinical investigation or \nmodification is to be subject, and \n\n(b) matters identified as possible adverse events that must be reported \nby the sponsor to the National REC should they occur in the \ncarrying out of the clinical investigation. \n\n \n \n \n \n\f8 [260] \n\n(4) If the opinion of the National REC is that the application is refused, the \n\nnotification under paragraph (2) shall include— \n\n(a) \n\n(b) \n\nthe reasons for the refusal, and \n\na statement that the person may appeal the refusal. \n\nNotification of acceptance of opinion or intention to appeal opinion", "text_norm": "13 (1) national rec considered relevant matter application regulation 8(1) (2) accordance eu regulation regulation national rec shall issue decision (in regulation referred opinion )-- (a) refusing give ethical approval satisfied one matter met (b) giving ethical approval proposal satisfied matter met (2) national rec shall notify-- (a) (b) applicant authority writing opinion paragraph (1) (3) opinion national rec application approved (with without conditions) notification paragraph (2) shall include statement of-- (a) condition clinical investigation modification subject (b) matter identified possible adverse event must reported sponsor national rec occur carrying clinical investigation 8 260 (4) opinion national rec application refused notification paragraph (2) shall include-- (a) (b) reason refusal statement person may appeal refusal notification acceptance opinion intention appeal opinion", "start_char": 13282, "end_char": 14695, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-14", "parent_doc_id": "si-2021-0260", "section_id": "reg-14", "section_label": "Regulation 14.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "14. Where a sponsor has been notified of an opinion, he or she shall notify", "text_raw": "14. Where a sponsor has been notified of an opinion, he or she shall notify \nthe National REC that issued the opinion, in writing, not later than 10 days after \nthe notification is sent, that he or she— \n\n(a) \n\naccepts the opinion, \n\n(b) does not accept the opinion but does not intend to appeal, or \n\n(c) \n\ndoes not accept the opinion and intends to appeal it. \n\nEffect of approval", "text_norm": "14 sponsor notified opinion shall notify national rec issued opinion writing later 10 day notification sent she-- (a) accepts opinion (b) accept opinion intend appeal (c) accept opinion intends appeal it effect approval", "start_char": 14695, "end_char": 15080, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-15", "parent_doc_id": "si-2021-0260", "section_id": "reg-15", "section_label": "Regulation 15.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "15. (1) Where an application or appeal is approved under these Regulations", "text_raw": "15. (1) Where an application or appeal is approved under these Regulations \nthat approval shall have effect in every investigation site specified in the \napplication. \n\n(2) No institution that is in receipt of any funding from the State, or research \nethics committee established or jointly established by such an institution, shall \nrequest or require, as a condition of research associated with a clinical \ninvestigation approved under these Regulations being carried out in that \ninstitution, that any examination of the matters referred to in Regulation 10 be \ndone. \n\n(3) Where an institution or research ethics committee referred to in \nparagraph (2) makes a request or imposes a requirement of the nature specified \nin that paragraph, the sponsor whose clinical investigation has been approved \nunder these Regulations shall notify the National REC that issued the opinion \ncontaining such approval of the request or requirement. \n\n(4) Upon receipt of a notification under paragraph (3), the National REC \nshall write to the institution or research ethics committee concerned and the \ninstitution or research ethics committee shall co-operate with any request for \ninformation made by the National REC under this paragraph. \n\nApplication for consent declaration", "text_norm": "15 (1) application appeal approved regulation approval shall effect every investigation site specified application (2) institution receipt funding state research ethic committee established jointly established institution shall request require condition research associated clinical investigation approved regulation carried institution examination matter referred regulation 10 done (3) institution research ethic committee referred paragraph (2) make request imposes requirement nature specified paragraph sponsor whose clinical investigation approved regulation shall notify national rec issued opinion containing approval request requirement (4) upon receipt notification paragraph (3) national rec shall write institution research ethic committee concerned institution research ethic committee shall co-operate request information made national rec paragraph application consent declaration", "start_char": 15080, "end_char": 16351, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-16", "parent_doc_id": "si-2021-0260", "section_id": "reg-16", "section_label": "Regulation 16.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "16. A sponsor making an application under Regulation 8(1) or (2) shall", "text_raw": "16. A sponsor making an application under Regulation 8(1) or (2) shall \nindicate, as part of the application, whether it is intended to make an application \nfor a consent declaration to the Health Research Consent Declaration Committee \nestablished by the Minister under the Data Protection Act 2018 (Section 36(2)) \n(Health Research) Regulations 2018 (S.I. No. 314 of 2018). \n\n \n \n \n \n \n \n\f[260] 9 \n\nAppeals from opinions", "text_norm": "16 sponsor making application regulation 8(1) (2) shall indicate part application whether intended make application consent declaration health research consent declaration committee established minister data protection act 2018 (section 36(2)) (health research) regulation 2018 (s.i no 314 2018) 260 9 appeal opinion", "start_char": 16351, "end_char": 16776, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-17", "parent_doc_id": "si-2021-0260", "section_id": "reg-17", "section_label": "Regulation 17.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "17. (1) A sponsor may, within 28 days of receipt of notification under", "text_raw": "17. (1) A sponsor may, within 28 days of receipt of notification under \nRegulation 13(2), bring an appeal against an opinion issued by a National REC \nunder these Regulations to an appeal panel established by the National REC. \n\n(2) A National REC shall publish guidelines setting out the procedures \n\napplicable to procedures under paragraph (1). \n\nOffences", "text_norm": "17 (1) sponsor may within 28 day receipt notification regulation 13(2) bring appeal opinion issued national rec regulation appeal panel established national rec (2) national rec shall publish guideline setting procedure applicable procedure paragraph (1) offence", "start_char": 16776, "end_char": 17137, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-18", "parent_doc_id": "si-2021-0260", "section_id": "reg-18", "section_label": "Regulation 18.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "18. (1) A person who—", "text_raw": "18. (1) A person who— \n\n(a) \n\n(b) \n\n(c) \n\n(d) \n\n(e) \n\nconducts a clinical investigation to which the EU Regulation \napplies contrary to an opinion or appeal decision under these \nRegulations \nfor such clinical \ninvestigation, \n\nrefusing ethical approval \n\nintroduces a modification to a clinical investigation to which \nArticle 75 of the EU Regulation applies without applying for and \nbeing granted approval for such modification under these \nRegulations, \n\ninvestigation approved under \n\nconducts a clinical \nthese \nRegulations without there being in place a policy of insurance or \nindemnity scheme to provide compensation for any damage \nsuffered by a subject resulting from participation in such clinical \ninvestigation in accordance with Regulation 11, \n\nin the course of an application or appeal under these Regulations, \nor the monitoring of a clinical investigation approved under these \nRegulations, makes any statement or representation, whether oral \nor written, that he or she knows to be false or misleading in any \nmaterial respect to a National REC, or \n\nknowingly makes any statement or representation, whether oral \nor written, that a clinical investigation that he or she is carrying \nout, or is planning to carry out or has carried out, has been \napproved by a National REC or an appeal panel if he or she knows \nthe statement or representation to be false or misleading, \n\nis guilty of an offence. \n\nPenalties and prosecution of offences", "text_norm": "18 (1) person who-- (a) (b) (c) (d) (e) conduct clinical investigation eu regulation applies contrary opinion appeal decision regulation clinical investigation refusing ethical approval introduces modification clinical investigation article 75 eu regulation applies without applying granted approval modification regulation investigation approved conduct clinical regulation without place policy insurance indemnity scheme provide compensation damage suffered subject resulting participation clinical investigation accordance regulation 11 course application appeal regulation monitoring clinical investigation approved regulation make statement representation whether oral written know false misleading material respect national rec knowingly make statement representation whether oral written clinical investigation carrying planning carry carried approved national rec appeal panel know statement representation false misleading guilty offence penalty prosecution offence", "start_char": 17137, "end_char": 18598, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-19", "parent_doc_id": "si-2021-0260", "section_id": "reg-19", "section_label": "Regulation 19.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "19. (1) A person who commits an offence under these Regulations is", "text_raw": "19. (1) A person who commits an offence under these Regulations is \n\nliable— \n\n(a) on a summary conviction, to a class B fine or imprisonment for a \n\nterm not exceeding 6 months, or both, or \n\n(b) on conviction on indictment, to a fine not exceeding €500,000 or \n\nimprisonment for a term not exceeding 3 years, or both. \n\n(2) Proceedings in relation to a summary offence under these Regulations \n\nmay be prosecuted by the Minister. \n\n \n \n \n\f10 [260] \n\nFees", "text_norm": "19 (1) person commits offence regulation liable-- (a) summary conviction class b fine imprisonment term exceeding 6 month (b) conviction indictment fine exceeding eur500 000 imprisonment term exceeding 3 year both (2) proceeding relation summary offence regulation may prosecuted minister 10 260 fee", "start_char": 18598, "end_char": 19057, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-20", "parent_doc_id": "si-2021-0260", "section_id": "reg-20", "section_label": "Regulation 20.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "20. (1) The following fees shall be payable by a sponsor to the relevant", "text_raw": "20. (1) The following fees shall be payable by a sponsor to the relevant \n\nNational REC: \n\n(a) €500 in respect of each application under Regulation 8(1), and \n\n€80 in respect of each trial site to which the application relates; \n\n(b) €125 in respect of each application under Regulation 8(2); and \n\n(c) \n\n€400 in respect of each appeal under Regulation 17 (which fee \nshall be refundable if the opinion appealed against is reversed or \nvaried). \n\n(2) Where a National REC is satisfied that an application relates to a non-\n\ncommercial clinical investigation, at the discretion of the National REC— \n\n(a) \n\n(b) \n\nthe fee payable under paragraph (1)(a) may be reduced to a single \nfee of €75, \n\nthe fee payable under paragraph (1)(b) may be reduced to €25, \nand \n\n(c) \n\nthe fee payable under paragraph (1)(c) may be reduced to €60. \n\n(3) The National REC may recover, as a simple contract debt in any court of \ncompetent jurisdiction, from the person by whom it is payable, any amount due \nand owing to it as a fee payable under this Regulation. \n\nTransitional arrangements", "text_norm": "20 (1) following fee shall payable sponsor relevant national rec (a) eur500 respect application regulation 8(1) eur80 respect trial site application relates (b) eur125 respect application regulation 8(2) (c) eur400 respect appeal regulation 17 (which fee shall refundable opinion appealed reversed varied) (2) national rec satisfied application relates non- commercial clinical investigation discretion national rec-- (a) (b) fee payable paragraph (1)(a) may reduced single fee eur75 fee payable paragraph (1)(b) may reduced eur25 (c) fee payable paragraph (1)(c) may reduced eur60 (3) national rec may recover simple contract debt court competent jurisdiction person payable amount due owing fee payable regulation transitional arrangement", "start_char": 19057, "end_char": 20131, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-21", "parent_doc_id": "si-2021-0260", "section_id": "reg-21", "section_label": "Regulation 21.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "21. (1) Where, at the date of the coming into operation of these Regulations,", "text_raw": "21. (1) Where, at the date of the coming into operation of these Regulations, \nan application for an ethics opinion is pending for consideration or under \nconsideration by an ethics committee in accordance with the provisions of the \nEuropean Communities (Medical Devices) Regulations 1994 (S.I. No. 252 of \n1994) or the European Communities (Active Implantable Medical Devices) \nRegulations 1994 (S.I. No. 253 of 1994), that committee shall not give any \nfurther consideration to the application and shall forward all papers and \ninformation relating to the application to the relevant National REC, and the \napplication shall be treated as an application under these Regulations. \n\n(2) The National REC shall, in relation to an application forwarded under \nparagraph (1), notify the applicant, in writing, that the application is being treated \nas if it was an application made under these Regulations and considered \naccordingly. \n\n \n \n \n \n \n \n \n \n\fSchedule \n\n[260] 11 \n\nRegulation 5 \n\nMembership and Procedural Matters relating to National RECs \n\nMembership", "text_norm": "21 (1) date coming operation regulation application ethic opinion pending consideration consideration ethic committee accordance provision european community (medical devices) regulation 1994 (s.i no 252 1994) european community (active implantable medical devices) regulation 1994 (s.i no 253 1994) committee shall give consideration application shall forward paper information relating application relevant national rec application shall treated application regulation (2) national rec shall relation application forwarded paragraph (1) notify applicant writing application treated application made regulation considered accordingly schedule 260 11 regulation 5 membership procedural matter relating national recs membership", "start_char": 20131, "end_char": 21195, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-1", "parent_doc_id": "si-2021-0260", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "1. (1) A National REC shall have no fewer than 15 members and no more than", "text_raw": "1. (1) A National REC shall have no fewer than 15 members and no more than \n28 members, including a chairperson, and 3 deputy chairpersons. \n\n(2) The chairperson, deputy chairpersons and ordinary members of a National \nREC shall be appointed by the Minister. \n\n(3) A National REC shall consist of persons who in the opinion of the Minister, \nhaving regard to the functions of the National REC concerned, are suitably \nqualified to serve as lay or expert members, as appropriate. \n\n(4) One quarter of the total members of a National REC shall be lay members. \n\n(5) The chairperson and the deputy chairpersons of a National REC shall each \nhold office for the period of 2 years from the date of his or her appointment, \nwhich period may be extended by one year. \n\n(6) An ordinary member of a National REC shall hold office for the period of 3 \nyears from the date of his or her appointment. \n\n(7) Subject to subparagraph (8), a member of a National REC whose term of \noffice expires by the efflux of time shall be eligible for reappointment to the \nNational REC. \n\n(8) A person who has served 2 consecutive terms of office as a member of a \nNational REC is not eligible for re-appointment to that National REC. \n\n(9) A person may not be a member of more than one National REC, at the same \ntime.", "text_norm": "1 (1) national rec shall fewer 15 member 28 member including chairperson 3 deputy chairperson (2) chairperson deputy chairperson ordinary member national rec shall appointed minister (3) national rec shall consist person opinion minister regard function national rec concerned suitably qualified serve lay expert member appropriate (4) one quarter total member national rec shall lay member (5) chairperson deputy chairperson national rec shall hold office period 2 year date appointment period may extended one year (6) ordinary member national rec shall hold office period 3 year date appointment (7) subject subparagraph (8) member national rec whose term office expires efflux time shall eligible reappointment national rec (8) person served 2 consecutive term office member national rec eligible re-appointment national rec (9) person may member one national rec time", "start_char": 21195, "end_char": 22491, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-2", "parent_doc_id": "si-2021-0260", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "2. (1) A member of a National REC may resign by written notice signed by him", "text_raw": "2. (1) A member of a National REC may resign by written notice signed by him \nor her to the Minister and the resignation shall take effect on the date of the \nmeeting of the National REC concerned next held after written notice of \nresignation is received by the Minister. \n\n(2) The Minister may at any time remove from office a member of a National \nREC if, in the Minister’s opinion— \n\n(a) the member has become incapable through ill-health of performing \nhis or her functions, \n\n(b) the member has committed stated misbehaviour of a type that would \nmake him or her unsuitable for membership of the National REC, or \n\n(c) the removal of the member appears to the Minister to be necessary \nfor the National REC to perform its functions effectively and with public \nconfidence. \n\n(3) If a member of a National REC dies, resigns, ceases to be qualified for office \nand ceases to hold office, or is removed from office, the Minister may appoint a \nperson to be a member to fill the casual vacancy so occasioned. \n\n \n \n\f12 [260] \n\n(4) A person appointed to be a member of a national REC under paragraph (3) \nholds office for that period of the term of office of the member who occasioned \nthe casual vacancy that remains unexpired at the date of his or her appointment \nand is eligible for reappointment as a member of the National REC for one term \nof office on the expiry of that period or such longer term, not exceeding 3 years, \nas the Minister may determine. \n\nMeetings", "text_norm": "2 (1) member national rec may resign written notice signed minister resignation shall take effect date meeting national rec concerned next held written notice resignation received minister (2) minister may time remove office member national rec minister opinion-- (a) member become incapable ill-health performing function (b) member committed stated misbehaviour type would make unsuitable membership national rec (c) removal member appears minister necessary national rec perform function effectively public confidence (3) member national rec dy resigns cease qualified office cease hold office removed office minister may appoint person member fill casual vacancy occasioned 12 260 (4) person appointed member national rec paragraph (3) hold office period term office member occasioned casual vacancy remains unexpired date appointment eligible reappointment member national rec one term office expiry period longer term exceeding 3 year minister may determine meeting", "start_char": 22491, "end_char": 23967, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-3", "parent_doc_id": "si-2021-0260", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "3. (1) The quorum for a meeting of the National REC (other than a subcommittee thereof) shall be 7, and at least one of those present shall be the", "text_raw": "3. (1) The quorum for a meeting of the National REC (other than a subcommittee thereof) shall be 7, and at least one of those present shall be the \nchairperson or a deputy chairperson. \n\n(2) Subject to subparagraph (1), the proceedings of a National REC shall not be \ninvalidated by any vacancy among its members.", "text_norm": "3 (1) quorum meeting national rec (other subcommittee thereof) shall 7 least one present shall chairperson deputy chairperson (2) subject subparagraph (1) proceeding national rec shall invalidated vacancy among member", "start_char": 23967, "end_char": 24283, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-4", "parent_doc_id": "si-2021-0260", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "4. (1) At least 5 working days before a meeting of a National REC, a notice in", "text_raw": "4. (1) At least 5 working days before a meeting of a National REC, a notice in \nwriting, signed by or on behalf of the chairperson of the National REC \nconcerned, or in the absence of the chairperson, by or on behalf of a deputy \nchairperson, shall be sent to every member of the National REC scheduled to \nattend the meeting and shall specify the agenda for that meeting. \n\n(2) At a meeting of the National REC— \n\n(a) the chairperson of the National REC shall, if present, be the \nchairperson of the meeting, \n\n(b) if and so long as the chairperson of the National REC is not present, \nor if that office is vacant, a deputy chairperson shall be the chairperson \nof the meeting. \n\nDecision Making", "text_norm": "4 (1) least 5 working day meeting national rec notice writing signed behalf chairperson national rec concerned absence chairperson behalf deputy chairperson shall sent every member national rec scheduled attend meeting shall specify agenda meeting (2) meeting national rec-- (a) chairperson national rec shall present chairperson meeting (b) long chairperson national rec present office vacant deputy chairperson shall chairperson meeting decision making", "start_char": 24283, "end_char": 24982, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-5", "parent_doc_id": "si-2021-0260", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "5. (1) Every question arising at a meeting of a National REC duly convened shall", "text_raw": "5. (1) Every question arising at a meeting of a National REC duly convened shall \nbe determined by a majority of the votes of the members of the National REC \npresent and voting on the question at a meeting of the National REC. \n\n(2) In the case of an equal division of votes on any question arising at a meeting \nof the National REC, the chairperson of the meeting shall have a second or \ncasting vote. \n\n(3) Where a member of a National REC has a material interest in any matter \nwhich falls to be considered by the National REC he or she shall- \n\n(a) disclose to the chairman of the National REC the nature of the interest \nin advance of any consideration of the matter, \n\n(b) neither influence nor seek to influence a decision relating to the \nmatter, \n\n(c) withdraw from a meeting or that part of a meeting at which the matter \nis being discussed or considered, and \n\n(d) take no part in any deliberation or decision relating to the matter. \n\n \n \n \n\f[260] 13 \n\n(4) For the purposes of this paragraph, but without prejudice to the generality of \nsubparagraph (3), a person is regarded as having a material interest if— \n\n(a) the person, a connected relative of the person or a nominee of either \nof them is a member of a company or any other body which has a \nbeneficial interest in, or material to, any matter to be considered under \nthat subparagraph, \n\n(b) the person or a connected relative of the person is in partnership with \nor is in the employment of a person who has a beneficial interest in, or \nmaterial to, any such matter, \n\n(c) the person or a connected relative is a party to any arrangement or \nagreement (whether or not enforceable) concerning land to which any \nsuch matter relates, or \n\n(d) a connected relative has a beneficial interest in, or material to, any \nsuch matter. \n\n(5) For the purposes of this paragraph, a person is not regarded as having a \nmaterial interest in any matter by reason only that he or she, or any company or \nother body or person mentioned in subparagraph (4), has an interest which is so \nremote or insignificant that it cannot reasonably be regarded as likely to \ninfluence a person in considering or discussing, or in voting on, any question in \nrespect of the matter or in performing any function in relation to the matter. \n\n(6) Where a material interest is disclosed under subparagraph (3), the disclosure \nshall be recorded in the minutes of the meeting concerned and, for so long as the \nmatter to which the disclosure relates is being dealt with by the meeting, the \nmember of the National REC by whom the disclosure is made shall not be \ncounted in the quorum for the meeting. \n\n(7) Where, at a meeting of a National REC, a question arises as to whether or \nnot a course of conduct, if pursued by a member of the National REC, would \nconstitute a failure by him or her to comply with the requirements of \nsubparagraph (3), the question may, subject to subparagraph (8), be determined \nby the chairperson of the meeting, whose decision shall be final, and where such \na question is so determined, particulars of the determination shall be recorded in \nthe minutes of the meeting. \n\n(8) Where, at a meeting of a National REC, the chairperson of the meeting is the \nperson in respect of whom a matter to which subparagraph (3) applies falls to be \ndetermined, the other members of the National REC attending the meeting shall \nchoose one of their number to be chairperson of the meeting for the purposes of \nsubparagraph (7). \n\n(9) Where the Minister is satisfied that a member of a National REC has not \ncomplied with subparagraph (3), the Minister may remove that member from \noffice and that person shall then be disqualified from being a member of that \nNational REC or any other National REC. \n\n(10) In this paragraph, “connected relative” in relation to a person, means a \nspouse, civil partner, parent, brother, sister, child or the spouse or civil partner \nof a child of the person. \n\n \n \n\f14 [260] \n\nMinutes", "text_norm": "5 (1) every question arising meeting national rec duly convened shall determined majority vote member national rec present voting question meeting national rec (2) case equal division vote question arising meeting national rec chairperson meeting shall second casting vote (3) member national rec material interest matter fall considered national rec shall- (a) disclose chairman national rec nature interest advance consideration matter (b) neither influence seek influence decision relating matter (c) withdraw meeting part meeting matter discussed considered (d) take part deliberation decision relating matter 260 13 (4) purpose paragraph without prejudice generality subparagraph (3) person regarded material interest if-- (a) person connected relative person nominee either member company body beneficial interest material matter considered subparagraph (b) person connected relative person partnership employment person beneficial interest material matter (c) person connected relative party arrangement agreement (whether enforceable) concerning land matter relates (d) connected relative beneficial interest material matter (5) purpose paragraph person regarded material interest matter reason company body person mentioned subparagraph (4) interest remote insignificant cannot reasonably regarded likely influence person considering discussing voting question respect matter performing function relation matter (6) material interest disclosed subparagraph (3) disclosure shall recorded minute meeting concerned long matter disclosure relates dealt meeting member national rec disclosure made shall counted quorum meeting (7) meeting national rec question arises whether course conduct pursued member national rec would constitute failure comply requirement subparagraph (3) question may subject subparagraph (8) determined chairperson meeting whose decision shall final question determined particular determination shall recorded minute meeting (8) meeting national rec chairperson meeting person respect matter subparagraph (3) applies fall determined member national rec attending meeting shall choose one number chairperson meeting purpose subparagraph (7) (9) minister satisfied member national rec complied subparagraph (3) minister may remove member office person shall disqualified member national rec national rec (10) paragraph connected relative relation person mean spouse civil partner parent brother sister child spouse civil partner child person 14 260 minute", "start_char": 24982, "end_char": 28961, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-6", "parent_doc_id": "si-2021-0260", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "6. (1) The chairperson of a meeting of the National REC shall cause proper", "text_raw": "6. (1) The chairperson of a meeting of the National REC shall cause proper \nminutes of the meeting to be prepared which shall be approved by the National \nREC at the next meeting of the National REC. \n\n(2) The names of all members present at a meeting of a National REC shall be \nrecorded in the minutes of the meeting. \n\nExpenses", "text_norm": "6 (1) chairperson meeting national rec shall cause proper minute meeting prepared shall approved national rec next meeting national rec (2) name member present meeting national rec shall recorded minute meeting expense", "start_char": 28961, "end_char": 29294, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-7", "parent_doc_id": "si-2021-0260", "section_id": "reg-7", "section_label": "Regulation 7.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "7. A member of a National REC may be paid such allowances in respect of", "text_raw": "7. A member of a National REC may be paid such allowances in respect of \nreasonable expenses as the Minister, with the consent of the Minister for Public \nExpenditure and Reform, determines. \n\nProcedures", "text_norm": "7 member national rec may paid allowance respect reasonable expense minister consent minister public expenditure reform determines procedure", "start_char": 29294, "end_char": 29500, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-8", "parent_doc_id": "si-2021-0260", "section_id": "reg-8", "section_label": "Regulation 8.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "8. Subject to these Regulations, a National REC shall determine its own", "text_raw": "8. Subject to these Regulations, a National REC shall determine its own \nprocedures, including that a member of a National REC may attend a meeting of \na National REC by remote means. \n\nGIVEN under my Official Seal, \n\n25 May, 2021. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f[260] 15", "text_norm": "8 subject regulation national rec shall determine procedure including member national rec may attend meeting national rec remote mean given official seal 25 may 2021 stephen donnelly minister health 260 15", "start_char": 29500, "end_char": 29816, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-explanatory-note", "parent_doc_id": "si-2021-0260", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations provide for the establishment of national research ethics \ncommittees for the purpose of ethical approval of clinical investigations of \nmedical devices, and lay down procedures and rules that apply to applications to \nsuch committees. \n\nThese Regulations may be cited as the European Union (National Research \nEthics Committee for Clinical Investigations of Medical Devices) Regulations", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation provide establishment national research ethic committee purpose ethical approval clinical investigation medical device lay procedure rule apply application committee regulation may cited european union (national research ethic committee clinical investigation medical devices) regulation", "start_char": 29816, "end_char": 30338, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
{"doc_id": "si-2021-0260-reg-2021", "parent_doc_id": "si-2021-0260", "section_id": "reg-2021", "section_label": "Regulation 2021.", "si_number": "S.I. No. 260 of 2021", "title": "1972) and for the purpose of giving further effect to Regulation (EU) 2017/745", "year": 2021, "heading": "16 [260]", "text_raw": "2021. \n\n \n \n \n \n \n \n \n\f16 [260] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \n52 FAICHE STIABHNA, BAILE ÁTHA CLIATH 2, \nD02 DR67. \n\nTeil: 076 110 6834 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \n52 ST. STEPHEN'S GREEN, DUBLIN 2, \nD02 DR67. \n\nTel: 076 110 6834 \nE-mail: publications@opw.ie \n—————— \n\n€3.50 \n\n(DH-253) 75. 5/21. Propylon.", "text_norm": "2021 16 260 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais 52 faiche stiabhna baile atha cliath 2 d02 dr67 teil 076 110 6834 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication 52 st stephen green dublin 2 d02 dr67 tel 076 110 6834 e-mail publication opw.ie ------------ eur3.50 (dh-253) 75 5 21 propylon", "start_char": 30338, "end_char": 30821, "source_path": "downloads\\2021\\2021_0260.pdf", "extraction_method": "pdfminer", "checksum": "sha256:f6d4657fa168053d8de51c4d88b66d70d12f42ebd4815895a9565bc7b26293f2", "cross_refs": []}
